RPP0C Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
RPP0C antibody; At3g11250 antibody; F11B9.17 antibody; F11B9_119 antibody; 60S acidic ribosomal protein P0-3 antibody
Target Names
RPP0C
Uniprot No.

Target Background

Function
Ribosomal protein P0 is the functional equivalent of *E. coli* protein L10.
Database Links

KEGG: ath:AT3G11250

STRING: 3702.AT3G11250.1

UniGene: At.17400

Protein Families
Universal ribosomal protein uL10 family

Q&A

What is RPP0C and why is it significant in research?

RPP0C (Ribosomal Protein P0 C) is a critical component of the ribosomal P-stalk structure involved in regulating protein translation by recruiting elongation factors. Its significance in research stems from its role in immune responses, particularly in plants where it contributes to basal resistance against bacterial infections such as Pseudomonas syringae. The phosphorylation status of P-stalk proteins, including RPP0, changes rapidly during immune responses and significantly affects translation regulation. Research has shown that RPP0C mutant plants demonstrate compromised resistance to bacterial infections, highlighting its importance in immunity mechanisms . Understanding RPP0C function has implications for both plant immunity research and potential applications in broader immunological studies.

How do RPP0C antibodies differ from other ribosomal protein antibodies?

RPP0C antibodies are specifically designed to target the C isoform of the P0 ribosomal protein, distinguishing them from antibodies that target other components of the P-stalk (such as RPP1, RPP2, or RPP3) or other ribosomal proteins. The specificity of RPP0C antibodies is particularly important given the dynamic phosphorylation changes that occur among P-stalk proteins during immune responses. While many ribosomal protein antibodies recognize structural components, RPP0C antibodies target proteins whose abundance in polysomes significantly decreases during immune activation . This makes them valuable tools for studying translation regulation during stress responses. The reliability of RPP0C antibodies, like all ribosomal protein antibodies, significantly impacts observed mRNA-protein correlations in research applications, with more reliable antibodies demonstrating stronger correlations between transcript and protein levels .

What are the recommended validation methods for RPP0C antibodies?

Validation of RPP0C antibodies should follow a multi-step approach to ensure specificity and reliability:

  • Western blot analysis - Testing against wild-type samples alongside RPP0C mutant controls to confirm specificity.

  • Immunoprecipitation followed by mass spectrometry - To verify that the antibody correctly pulls down RPP0C and its known interaction partners.

  • Immunolocalization studies - To confirm the expected ribosomal/cytoplasmic localization pattern.

  • Peptide competition assays - Using synthesized RPP0C peptides to demonstrate binding specificity.

  • Cross-reactivity testing - Against related P-stalk proteins (RPP1, RPP2, RPP3) to ensure specificity.

Research indicates that antibody reliability significantly influences observed mRNA-protein correlations, making proper validation critical for accurate experimental outcomes. Proteins measured with less reliable antibodies consistently show lower observed mRNA-protein correlations in large-scale studies . For RPP0C specifically, validation against known phosphorylation states is also recommended, as its phosphorylation status changes during immune responses.

How can RPP0C antibodies be used to study translational regulation during immune responses?

RPP0C antibodies provide powerful tools for investigating translational regulation during immune responses through several sophisticated approaches:

  • Polysome profiling with immunoblotting - This technique allows researchers to track the association of RPP0C with actively translating ribosomes (polysomes) before and after immune stimulation. Research has shown that MAMP (microbe-associated molecular patterns) activation induces rapid changes in ribosomal protein composition of monosomes, polysomes, and the 60S ribosomal subunit . RPP0C antibodies can detect these changes, revealing how immune activation alters the translation machinery.

  • Phosphorylation-specific antibody applications - Specialized RPP0C antibodies that recognize specific phosphorylation states can track how MAMP-activation regulates the phosphorylation status of P-stalk proteins. Studies have demonstrated that immune activation triggers phosphorylation of RPP0 with concurrent dephosphorylation of RPP1 and RPP2 .

  • Co-immunoprecipitation studies - RPP0C antibodies can pull down associated proteins to identify interactions that change during immune activation, particularly with translation elongation factors that are recruited by the P-stalk.

  • Time-course analyses - By sampling at different timepoints after immune stimulation, researchers can use RPP0C antibodies to track the dynamics of P-stalk composition and phosphorylation, which correlate with the observed reduction in bulk translation during stress responses.

These approaches collectively enable researchers to understand how pathogens trigger translational reprogramming through modifications of the P-stalk structure.

What are the considerations when using RPP0C antibodies for comparing wild-type and mutant plant phenotypes?

When using RPP0C antibodies to compare wild-type and mutant plant phenotypes, researchers should consider several critical factors:

  • Genetic background standardization - Ensure that mutant lines (such as mpk6-2) are properly backcrossed to the wild-type (e.g., Columbia-0) to minimize background genetic differences that could confound results .

  • Experimental design parameters:

    • Control for developmental stage, as ribosome composition changes throughout development

    • Standardize growth conditions including temperature, light cycles, and humidity

    • Apply uniform treatment protocols (e.g., 15 min with 1 μM flg22 treatment)

    • Include appropriate biological replicates (minimum three biological repeats)

  • Detection sensitivity optimization - Adjust antibody concentrations specifically for detecting RPP0C in different types of samples (whole cell lysates vs. purified ribosomes) from both wild-type and mutant plants.

  • Complementation controls - Include transgenic complementation lines expressing RPP0C in the rpp0c mutant background to confirm phenotypic differences are specifically due to RPP0C deficiency.

  • Parallel analysis of related P-stalk proteins - Monitor changes in other P-stalk components (RPP1, RPP2, RPP3) simultaneously, as they function as a coordinated unit and may show compensatory changes in mutant backgrounds.

Research has demonstrated that RPP0C mutant plants exhibit compromised resistance to bacterial pathogens like Pseudomonas syringae, providing a clear phenotypic readout for functional studies . When designed with these considerations, comparative studies can reveal the specific contribution of RPP0C to immune function and translational regulation.

How can native and phosphorylation-specific RPP0C antibodies be used together in research?

Combining native and phosphorylation-specific RPP0C antibodies creates a powerful approach for dissecting the dynamic regulation of translation during immune responses:

These antibodies can be deployed in a sequential experimental workflow:

  • Dual immunoprecipitation strategy - First use native antibodies to pull down total RPP0C, then probe with phospho-specific antibodies to determine the proportion of phosphorylated protein.

  • Temporal dynamics analysis - Apply both antibody types across a time course after immune stimulation to track both the total abundance of RPP0C in polysomes (which decreases significantly during immune activation) and its phosphorylation status (which increases) .

  • Spatial distribution studies - Employ both antibody types in immunolocalization experiments to determine whether phosphorylated RPP0C shows different subcellular distribution compared to the total RPP0C pool.

Research has shown that MAMP-activation of MPK6 regulates the phosphorylation status of P-stalk ribosomal proteins, with phosphorylation of RPP0 occurring simultaneously with dephosphorylation of RPP1 and RPP2 . Using both antibody types provides comprehensive insight into these coordinated modifications that regulate translation during stress responses.

What protocols yield optimal results for immunoprecipitation with RPP0C antibodies?

For optimal immunoprecipitation results with RPP0C antibodies, the following protocol refinements are recommended based on research practices:

  • Sample preparation specifics:

    • Extract plant tissues in buffer containing 100 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40, with fresh addition of protease inhibitors and phosphatase inhibitors

    • Include 1 mM EDTA to preserve ribosome integrity while preventing contaminating nuclease activity

    • Flash-freeze tissues in liquid nitrogen and grind thoroughly to ensure complete lysis

  • Pre-clearing step - Incubate lysates with protein A/G beads for 1 hour at 4°C before adding the RPP0C antibody to reduce non-specific binding

  • Antibody binding optimization:

    • Use 2-5 μg of RPP0C antibody per 1 mg of total protein

    • Incubate overnight at 4°C with gentle rotation

    • For phosphorylation studies, supplement buffers with 10 mM sodium fluoride and 1 mM sodium orthovanadate

  • Washing stringency gradient - Implement a gradient of washing stringency:

    • First wash: IP buffer with standard salt concentration

    • Second wash: Increased salt concentration (250 mM NaCl)

    • Final wash: Buffer without detergent to remove residual detergent

  • Elution options:

    • For western blot analysis: Elute directly in SDS sample buffer at 95°C for 5 minutes

    • For mass spectrometry: Consider gentler elution with competing peptides

Research examining ribosomal protein interactions has demonstrated that these optimized immunoprecipitation conditions maintain the integrity of the P-stalk complex while efficiently isolating RPP0C and its associated proteins . These methods have been successfully applied to detect changes in the phosphorylation status and interactions of P-stalk proteins during immune responses.

How should researchers design experiments to compare RPP0C localization before and after immune stimulation?

When designing experiments to compare RPP0C localization before and after immune stimulation, researchers should implement the following comprehensive approach:

  • Stimulation protocol standardization:

    • Use purified MAMPs such as flg22 at 1 μM concentration

    • Establish a precise time course (e.g., 0, 15, 30, 60 minutes post-stimulation)

    • Include both mock-treated controls and positive controls (e.g., known translocation markers)

  • Fixation method selection:

    • For immunofluorescence: 4% paraformaldehyde fixation with phosphate buffer (pH 7.0)

    • For electron microscopy studies: Glutaraldehyde-paraformaldehyde mixed fixative

    • Ensure rapid fixation to capture transient localization changes

  • Antibody validation for localization:

    • Confirm specificity using rpp0c mutant tissues as negative controls

    • Validate with both C-terminal and N-terminal epitope-targeted antibodies

    • Perform peptide competition assays to confirm signal specificity

  • Co-localization markers:

    • Ribosomal markers (e.g., RPL5) to confirm association with ribosomes

    • Endoplasmic reticulum markers to track ribosome-associated RPP0C

    • P-body markers to detect potential sequestration during translation inhibition

  • Quantification approach:

    • Implement automated image analysis with consistent thresholding

    • Quantify co-localization coefficients (e.g., Pearson's correlation)

    • Analyze minimum 100 cells across 3 biological replicates for statistical robustness

These design elements address the challenge of tracking potentially subtle changes in RPP0C distribution. Research has shown that immune activation triggers changes in the composition of translating ribosomes, with a significant decrease in the abundance of ribosome-bound RPP0s in polysomes . Well-designed localization studies can visualize these shifts and correlate them with the observed reduction in bulk translation during immune responses.

What are the critical parameters for western blot detection of RPP0C in different plant tissue types?

Western blot detection of RPP0C requires careful optimization across different plant tissue types due to variations in protein abundance, extraction difficulty, and potential interfering compounds. The following parameters are critical:

  • Extraction buffer composition by tissue type:

Tissue TypeBuffer ModificationRationale
Leaf tissueStandard extraction with 0.5% Triton X-100Moderate cell wall barrier
Root tissueIncrease to 1% Triton X-100, add 1% PVPHigher phenolic compounds
Meristematic tissueAdd 5mM EDTA, 1mM PMSFHigh protease activity
Seed tissueInclude 10mM DTT, sonication stepDense tissue, disulfide bonds
  • Sample loading normalization:

    • For comparative studies, normalize to total protein using stain-free technology rather than single reference proteins

    • Load 20-30 μg total protein for standard detection of RPP0C

    • For phosphorylation studies, consider loading up to 50 μg to detect potentially low-abundance phosphorylated forms

  • Membrane selection and transfer conditions:

    • PVDF membranes (0.45 μm) provide optimal results for RPP0C detection

    • Transfer at 100V for 1 hour in 10% methanol transfer buffer

    • Confirm transfer efficiency with reversible staining before blocking

  • Antibody dilution optimization:

    • Primary RPP0C antibody: 1:1000 to 1:2000 dilution in 5% BSA

    • For phospho-specific antibodies: More concentrated 1:500 dilution

    • Extended overnight incubation at 4°C improves signal-to-noise ratio

  • Signal development considerations:

    • For standard detection: ECL substrates are sufficient

    • For phosphorylation studies: Use high-sensitivity femto-ECL systems

    • Consider fluorescent secondary antibodies for multiplex detection with other P-stalk proteins

Research examining P-stalk protein dynamics during immune responses has demonstrated that these optimized western blot parameters enable reliable detection of both total RPP0C and its phosphorylated forms. These methods have successfully shown that MAMP activation triggers changes in RPP0C phosphorylation status that correlate with altered translation .

How should researchers interpret discrepancies between RPP0C protein levels and mRNA expression?

When researchers encounter discrepancies between RPP0C protein levels (detected via antibodies) and mRNA expression (measured by RT-PCR or RNA-seq), the following interpretative framework should be applied:

Research on ribosomal proteins has shown that correlations between mRNA and protein levels can be influenced by antibody reliability, with less reliable antibodies yielding lower observed correlations . Additionally, stress responses (like immune activation) can rapidly alter translation efficiency, creating temporary mismatches between transcript and protein levels as part of the cellular response mechanism . In the case of RPP0C specifically, immune activation triggers both phosphorylation changes and dissociation from polysomes, potentially affecting detection without changing total protein levels.

What statistical approaches are recommended for analyzing RPP0C phosphorylation data across experimental conditions?

For robust analysis of RPP0C phosphorylation data across experimental conditions, researchers should implement the following statistical approaches:

  • Data normalization methods:

    • Normalize phosphorylation signals to total RPP0C protein levels to account for variations in total protein

    • Apply global normalization techniques (VSN or quantile normalization) for large-scale phosphoproteomic datasets

    • Consider using spike-in standards for absolute quantification in comparative studies

  • Statistical testing hierarchy:

    • Initial screening: ANOVA with post-hoc tests for multi-condition experiments

    • Pairwise comparisons: Student's t-test with appropriate multiple testing correction (Benjamini-Hochberg)

    • Time-course analysis: Mixed-effects modeling to account for repeated measures

  • Correlation analysis with functional outcomes:

    • Pearson correlation between RPP0C phosphorylation levels and translation efficiency measurements

    • Regression analysis to model relationship between phosphorylation status and bacterial resistance

    • Principal component analysis to identify patterns across multiple P-stalk phosphorylation sites

  • Visualization recommendations:

    • Heatmaps for displaying phosphorylation patterns across conditions

    • Box plots with individual data points for showing distribution and variability

    • Time-course line graphs with error bands for temporal dynamics

  • Effect size reporting:

    • Include fold-change values alongside p-values

    • Report confidence intervals for all measurements

    • Calculate standardized effect sizes (Cohen's d) for key comparisons

Research on P-stalk protein dynamics has shown that MAMP-activation of MPK6 regulates the phosphorylation status of P-stalk proteins in a coordinated manner, with RPP0 phosphorylation occurring simultaneously with dephosphorylation of RPP1 and RPP2 . Statistical analysis of these patterns requires methods that can account for this coordination while distinguishing significant changes from technical variability.

How can researchers distinguish between RPP0C antibody signal specificity issues and genuine biological variability?

Distinguishing between antibody specificity issues and genuine biological variability is a critical challenge when working with RPP0C antibodies. Researchers should implement this comprehensive troubleshooting framework:

  • Control experiment hierarchy:

Control TypeImplementationInterpretation
Genetic controlsInclude rpp0c mutant samplesShould show minimal/no signal
Blocking peptidePre-incubate antibody with immunizing peptideShould eliminate specific signal
Loading controlsMonitor multiple reference proteinsShould remain stable across conditions
Cross-reactivity testProbe purified RPP1, RPP2, RPP3 proteinsShould show minimal cross-reactivity
  • Signal validation through orthogonal methods:

    • Confirm key findings using alternative detection antibodies targeting different RPP0C epitopes

    • Validate with mass spectrometry-based approaches for absolute quantification

    • Implement genetic complementation experiments to confirm functional relevance

  • Pattern recognition approach:

    • Biological variability typically shows patterns correlated with physiological states

    • Antibody specificity issues often produce random variation or systematic bias

    • Compare patterns across multiple experiments and biological replicates

  • Quantitative assessment tools:

    • Calculate intra-class correlation coefficients to assess technical reproducibility

    • Implement variance component analysis to partition biological vs. technical variance

    • Use bootstrapping approaches to establish confidence intervals for measurements

Research on ribosomal proteins has demonstrated that antibody reliability significantly influences observed protein measurements and correlations with mRNA levels . For RPP0C specifically, genuine biological variation has been observed during immune responses, including changes in phosphorylation status and abundance in polysomes . By implementing these approaches, researchers can confidently distinguish between technical artifacts and the biologically significant dynamics of RPP0C during cellular responses.

What are common pitfalls when using RPP0C antibodies in immunoprecipitation experiments?

Researchers working with RPP0C antibodies in immunoprecipitation experiments should be aware of these common pitfalls and their solutions:

  • Co-precipitation interference issues:

    • Pitfall: Failure to detect RPP0C interaction partners due to antibody binding at interaction interfaces

    • Solution: Use multiple antibodies targeting different RPP0C epitopes; consider epitope-tagged RPP0C expression systems

  • P-stalk complex instability:

    • Pitfall: Loss of native interactions between RPP0C and other P-stalk proteins during extraction

    • Solution: Use gentle extraction buffers with reduced detergent (0.1% NP-40); maintain samples at 4°C throughout processing

  • Phosphorylation state preservation:

    • Pitfall: Loss of phosphorylation signals critical for understanding RPP0C regulation

    • Solution: Include phosphatase inhibitor cocktails with both serine/threonine and tyrosine phosphatase inhibitors; process samples rapidly

  • Background binding issues:

    • Pitfall: High background from ribosomal proteins binding non-specifically to beads

    • Solution: Implement stringent pre-clearing steps; use IP buffer with 150-250mM salt; consider native elution with competing peptides

  • Antibody cross-reactivity:

    • Pitfall: False positive signals from antibodies recognizing related P-stalk proteins

    • Solution: Validate specificity with RPP0C knockout/mutant controls; perform parallel IPs with antibodies against related proteins

Research has shown that during immune responses, the interaction landscape of P-stalk proteins changes significantly, with RPP0 phosphorylation coinciding with altered associations within the ribosome . Properly optimized immunoprecipitation protocols are essential for capturing these dynamic changes without introducing artifacts. Particularly important is the preservation of phosphorylation states, as MAMP-activation triggers significant phosphorylation changes in P-stalk proteins that regulate their function in translation.

How can researchers optimize detection sensitivity for low-abundance RPP0C modifications?

Detecting low-abundance RPP0C modifications, particularly specific phosphorylation states that emerge during immune responses, requires specialized optimization approaches:

  • Sample enrichment strategies:

    • Implement polysome fractionation to concentrate ribosome-associated RPP0C

    • Use phospho-peptide enrichment techniques (TiO₂ or IMAC) prior to analysis

    • Apply antibody-based enrichment with pan-RPP0C antibodies before probing for specific modifications

  • Signal amplification techniques:

    • Employ tyramide signal amplification for immunofluorescence detection

    • Use high-sensitivity chemiluminescent substrates for western blots

    • Consider quantum dot-conjugated secondary antibodies for improved signal-to-noise ratio

  • Instrument parameter optimization:

    • For western blots: Extended exposure times with low-noise cameras

    • For mass spectrometry: Targeted methods (PRM/MRM) focused on known modification sites

    • For microscopy: Optimize for high numerical aperture and extended acquisition times

  • Chemical biology approaches:

    • Utilize phosphatase inhibitors to preserve labile modifications

    • Apply crosslinking strategies to capture transient interactions

    • Consider proximity labeling techniques to identify the modification environment

  • Computational enhancement methods:

    • Implement deconvolution algorithms for microscopy images

    • Apply noise reduction techniques for western blot quantification

    • Use machine learning approaches to extract patterns from complex datasets

Research has demonstrated that MAMP-activation triggers specific phosphorylation changes in RPP0C that are functionally important but potentially present at low stoichiometry . These modifications coincide with decreased association of RPP0 with polysomes, making their detection particularly challenging. By implementing these optimizations, researchers can reliably detect these critical regulatory modifications that link immune activation to translational control.

What experimental design approaches help resolve contradictory findings with RPP0C antibodies?

When faced with contradictory results using RPP0C antibodies, researchers should implement the following systematic experimental design approaches to resolve discrepancies:

  • Multi-antibody validation strategy:

    • Test multiple antibodies targeting different epitopes of RPP0C

    • Include both commercial and custom-developed antibodies

    • Compare monoclonal vs. polyclonal antibodies for epitope accessibility differences

  • Genetic complementation framework:

    • Use CRISPR/Cas9-generated RPP0C knockout/mutant lines as negative controls

    • Implement rescue experiments with tagged RPP0C variants for parallel detection

    • Consider epitope-tagged endogenous RPP0C using knock-in approaches

  • Method triangulation approach:

    • Combine antibody-based detection with mass spectrometry validation

    • Correlate protein findings with transcriptomics data while accounting for post-transcriptional regulation

    • Implement functional assays to connect molecular observations with biological outcomes

  • Standardized reporting protocol:

    • Document detailed antibody information (source, lot, validation)

    • Maintain consistent sample preparation across experiments

    • Implement blinded analysis procedures to reduce investigator bias

  • Systematic variable isolation:

    • Design factorial experiments to test interaction effects between variables

    • Implement DOE (Design of Experiments) approaches to efficiently test multiple parameters

    • Use statistical approaches like ANOVA to identify significant sources of variation

Research on ribosomal proteins has shown that antibody reliability significantly influences observed protein measurements and correlations with mRNA levels . For RPP0C specifically, conflicting results might arise from differences in phosphorylation states, association with ribosomes, or tissue-specific expression patterns. By systematically addressing these variables, researchers can reconcile contradictory findings and develop a more complete understanding of RPP0C biology.

How might single-cell applications of RPP0C antibodies advance our understanding of cellular heterogeneity?

Single-cell applications of RPP0C antibodies represent a frontier in understanding translation regulation heterogeneity during immune responses and stress conditions:

  • Technical implementation approaches:

    • Adapt RPP0C antibodies for compatibility with mass cytometry (CyTOF) using metal conjugation

    • Develop fluorescent nanobody versions of RPP0C antibodies for live-cell imaging

    • Optimize RPP0C antibodies for single-cell Western blot technologies

    • Implement spatial transcriptomics approaches combined with RPP0C protein detection

  • Biological questions addressable with single-cell RPP0C analysis:

    • Cell-to-cell variation in translational reprogramming during immune responses

    • Identification of pioneer cells that initiate translational changes in tissues

    • Correlation between RPP0C modification states and cell cycle position

    • Microenvironment influences on translation regulation at single-cell resolution

  • Integration with other single-cell technologies:

    • Combine with single-cell RNA-seq to correlate transcriptome and RPP0C status

    • Implement with ribosome profiling at single-cell level for translation efficiency

    • Integrate with single-cell proteomics for broader protein network context

  • Computational analysis requirements:

    • Develop clustering algorithms specifically for translation-related protein modifications

    • Implement trajectory analysis to map translational state transitions

    • Create visualization tools for spatiotemporal patterns of RPP0C modifications

Research has established that RPP0C plays a critical role in immune responses, with changes in its phosphorylation state occurring during pathogen detection . Single-cell approaches would reveal whether these changes occur uniformly across a tissue or whether certain cells act as "sentinel" cells that undergo more dramatic translational reprogramming. This heterogeneity information could fundamentally change our understanding of how translation regulation contributes to immune responses at the tissue level.

What advances in antibody technology might improve RPP0C research in the coming years?

Emerging antibody technologies are poised to transform RPP0C research in several significant ways:

  • Next-generation antibody formats:

    • Nanobodies and single-domain antibodies: Their small size (approximately 15 kDa) enables access to epitopes that might be sterically hindered in the P-stalk complex. Research with nanobodies targeting other proteins has demonstrated their exceptional specificity and ability to recognize conformational epitopes .

    • Bispecific antibodies: Simultaneously targeting RPP0C and other P-stalk proteins to study their co-regulation during stress responses

    • Intrabodies: Genetically encoded antibody fragments expressed within cells for real-time monitoring of RPP0C dynamics

  • Enhanced modification-specific approaches:

    • Development of antibodies with improved specificity for phosphorylated RPP0C at multiple sites

    • Conformation-specific antibodies that distinguish between active and inactive RPP0C states

    • Proximity-sensing antibody pairs that fluoresce only when RPP0C interacts with translation factors

  • Production technology improvements:

    • Recombinant antibody production systems with precise glycosylation control

    • Site-specific conjugation methods for reporter molecules with minimal interference

    • Rapid epitope mapping technologies to select optimal antibody candidates

  • Integration with emerging technologies:

    • Antibody-DNA conjugates for ultrasensitive digital detection of RPP0C

    • Optogenetic antibody systems with light-controlled binding properties

    • CRISPR-based epitope tagging for endogenous protein detection

Research has demonstrated that antibody-based tools can dramatically advance protein research, as seen with the development of nanobodies that successfully target previously challenging proteins . For RPP0C specifically, these advances would enable more precise monitoring of its dynamic changes during immune responses, particularly the phosphorylation events that regulate its function in translation .

How might RPP0C antibodies contribute to translational medicine research beyond plant immunity?

While RPP0C has been primarily studied in plant immunity contexts, RPP0C antibodies have significant potential to advance translational medicine research in several directions:

  • Comparative immunology applications:

    • Investigation of conserved translation regulation mechanisms between plant and animal immune systems

    • Study of P-stalk protein dynamics during pathogen infections across kingdoms

    • Exploration of evolutionary conservation in stress-induced translational reprogramming

  • Cancer research potential:

    • Analysis of P-stalk protein dysregulation in cancer cells with altered translation profiles

    • Investigation of RPP0C phosphorylation states in therapy-resistant tumors

    • Development of diagnostic approaches based on ribosome composition signatures

    • Research has demonstrated that antibody-based tools, like those developed for other proteins, can significantly advance cancer research by providing precise targeting capability

  • Neurodegenerative disease connections:

    • Examination of translation dysregulation in protein misfolding disorders

    • Investigation of stress granule formation and P-stalk protein localization

    • Analysis of ribosome heterogeneity in affected neural tissues

  • Therapeutic implications:

    • Development of small molecule modulators of P-stalk function based on antibody epitope mapping

    • Creation of antibody-drug conjugates targeting cells with aberrant RPP0C modifications

    • Design of therapeutic approaches to restore normal translation regulation in disease states

  • Biotechnology applications:

    • Engineering of translation systems with modified P-stalk components for specialized protein production

    • Development of biosensors using RPP0C-based detection systems for cellular stress

    • Creation of diagnostic tools based on translation machinery signatures

The fundamental role of P-stalk proteins in translation regulation makes them relevant across biological systems. Research has established that translation regulation is a critical point of control in both immunity and disease processes . RPP0C antibodies provide powerful tools to investigate these mechanisms, potentially revealing therapeutic targets and diagnostic markers with broad applicability in both plant and animal systems.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.